$HIMS is up another 5.84% today. Andrew Dudum also gave a great interview on CNBC this week. He clearly explained his vision for AI-powered healthcare, more affordable GLP-1s and directly addressed the FTC lawsuit. He came across incredibly well. If this momentum continues, I don’t think we’ll ever see the stock below $30 again.
View on X ↗